GSK (GSK)

Sector:

Pharma and Biotech

Index:

FTSE 100

1,855.00p
   
  • Change Today:
      41.00p
  • 52 Week High: 2,208.00p
  • 52 Week Low: 1,735.50p
  • Currency: UK Pounds
  • Shares Issued: 4,045.43m
  • Volume: 13,548,350
  • Market Cap: £75,043m
  • RiskGrade: 129
  • Beta: 0.00

Dividends

Year End Type Amount Payment Date Ex-Div Date Record Date
31-Dec-22 Q1 14.00p 01-Jul-22 19-May-22 20-May-22
  Q2 16.25p 06-Oct-22 18-Aug-22 19-Aug-22
  Q3 13.75p 12-Jan-23 17-Nov-22 18-Nov-22
  Q4 13.75p 13-Apr-23 23-Feb-23 24-Feb-23
31-Dec-23 Q1 14.00p 13-Jul-23 18-May-23 19-May-23
  Q2 14.00p 12-Oct-23 17-Aug-23 18-Aug-23
  Q3 14.00p 11-Jan-24 16-Nov-23 17-Nov-23
  Q4 16.00p 11-Apr-24 22-Feb-24 23-Feb-24
31-Dec-24 Q1 15.00p 11-Jul-24 16-May-24 17-May-24
  Q2 15.00p 10-Oct-24 15-Aug-24 16-Aug-24
  Q3 15.00p 09-Jan-25 14-Nov-24 15-Nov-24
  Q4 16.00p 10-Apr-25 20-Feb-25 21-Feb-25
31-Dec-25 Q1 16.00p 10-Jul-25 15-May-25 16-May-25
  Q2 16.00p 09-Oct-25 14-Aug-25 15-Aug-25
  Q3 16.00p 08-Jan-26 13-Nov-25 14-Nov-25
  Q4 18.00p 09-Apr-26 19-Feb-26 20-Feb-26
31-Dec-26 Q1 17.00p 09-Jul-26 14-May-26 15-May-26
  Q2 17.00p 08-Oct-26 13-Aug-26 14-Aug-26
  Q3 17.00p 07-Jan-27 12-Nov-26 13-Nov-26

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Historical interim dividends and record dates not previously collected

Note 4: Forecast figures based on normalised accounts.

 

IFRS Changes - Find Out More

Find out about IFRS and how this affects the financial infomation for all UK companies.

GSK Market Data

Currency UK Pounds
Share Price 1,855.00p
Change Today 41.00p
% Change 2.26 %
52 Week High 2,208.00p
52 Week Low 1,735.50p
Volume 13,548,350
Shares Issued 4,045.43m
Market Cap £75,043m
Beta 0.00
RiskGrade 129

GSK Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
78.37% below the market average78.37% below the market average78.37% below the market average78.37% below the market average78.37% below the market average
7.32% above the sector average7.32% above the sector average7.32% above the sector average7.32% above the sector average7.32% above the sector average
Price Trend
75.05% above the market average75.05% above the market average75.05% above the market average75.05% above the market average75.05% above the market average
67.44% above the sector average67.44% above the sector average67.44% above the sector average67.44% above the sector average67.44% above the sector average
Income
19.64% above the market average19.64% above the market average19.64% above the market average19.64% above the market average19.64% above the market average
33.33% above the sector average33.33% above the sector average33.33% above the sector average33.33% above the sector average33.33% above the sector average
Growth
41.70% above the market average41.70% above the market average41.70% above the market average41.70% above the market average41.70% above the market average
57.14% below the sector average57.14% below the sector average57.14% below the sector average57.14% below the sector average57.14% below the sector average

What The Brokers Say

Strong Buy 4
Buy 3
Neutral 12
Sell 2
Strong Sell 0
Total 21
neutral
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

GSK Dividends

  Latest Previous
  Q3 Q2
Ex-Div 12-Nov-26 13-Aug-26
Paid 07-Jan-27 08-Oct-26
Amount 17.00p 17.00p

Trades for 30-Oct-2026

Time Volume / Share Price
15:57 2,379,885 @ 1,838.00p
15:57 2,379,885 @ 1,838.00p
16:38 220,205 @ 1,857.80p
16:36 898 @ 1,855.00p
16:36 2,396 @ 1,855.00p

GSK Key Personnel

CEO Luke Miels

Top of Page